22 Dec Risks of cardiac valve regurgitation and heart failure associated with ergot- and non-ergot-derived dopamine agonist use in patients with Parkinson’s disease: A systematic review of observational studies
Posted at 12:14h
in
Tran T, Brophy JM, Suissa S, Renoux C. Risks of cardiac valve regurgitation and heart failure associated with ergot-and non-ergot-derived dopamine agonist use in patients with Parkinson’s disease: A systematic review of observational studies. CNS Drugs. 2015 Dec;29(12):985-98.